Corcept Therapeutics reported $44.76M in Current Liabilities for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Current Liabilities Change
Acadia Pharmaceuticals ACAD:US $ 88.22M 7.11M
Ani Pharmaceuticals ANIP:US $ 84.87M 4.58M
Aphria Inc APH:CN C$ 216.99M 75.99M
Ardelyx ARDX:US $ 68.77M 10.98M
Aurora Cannabis Inc ACB:CN 120.39M 4.02M
Biodelivery Sciences International BDSI:US $ 77.66M 13.75M
Biomarin Pharmaceutical BMRN:US $ 514.9M 71.55M
Bristol Myers Squibb BMY:US $ 21460M 2469M
Canopy Growth Corp WEED:CN C$ 259.9M 3.77M
Corcept Therapeutics CORT:US $ 44.76M 0.64M
Depomed DEPO:US $ 100.48M 16.43M
Eleven Biotherapeutics EBIO:US $ 12.59M 6.23M
Eli Lilly And LLY:US $ 13682M 1411.2M
Esperion Therapeutics ESPR:US $ 78.48M 4.16M
Gw Pharmaceuticals GWPH:US $ 160.25M 0.44M
Knight Therapeutics Inc GUD:CN C$ 132.55M 14.78M
Lannett LCI:US $ 112.28M 21.81M
Nektar Therapeutics NKTR:US $ 139.97M 8.95M
Novartis NVS:US $ 29880M 247M
Novartis NOVN:VX SF 29880M 247M
Omeros OMER:US $ 42.82M 4.88M
Pacira Pharmaceuticals PCRX:US $ 225.79M 2.9M
Supernus Pharmaceuticals SUPN:US $ 234.71M 48.74M
Ziopharm Oncology ZIOP:US $ 28.17M 14.58M